General Information of the Compound
| Compound ID |
CP0859593
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(R)-2-(4-(3,5-Difluorobenzoyl)piperazin-1-yl)-2-phenyl-N-((6-(trifluoromethyl)pyridin-3-yl)methyl)acetamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H23F5N4O2
|
||||||||||||||||||
| Molecular Weight |
518.486
|
||||||||||||||||||
| Canonical SMILES |
O=C(NCc1ccc(C(F)(F)F)nc1)[C@@H](c1ccccc1)N1CCN(C(=O)c2cc(F)cc(F)c2)CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H23F5N4O2/c27-20-12-19(13-21(28)14-20)25(37)35-10-8-34(9-11-35)23(18-4-2-1-3-5-18)24(36)33-16-17-6-7-22(32-15-17)26(29,30)31/h1-7,12-15,23H,8-11,16H2,(H,33,36)/t23-/m1/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
LUBXXVBEWNTQCJ-HSZRJFAPSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01105, Sodium channel protein type 5 subunit alpha
Protein ID: PT01000, Sodium channel protein type 9 subunit alpha